Sep 5 |
Moderna updated COVID shot endorsed in EU
|
Sep 5 |
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
|
Sep 4 |
Is It Time to Buy August's Worst-Performing S&P 500 Stocks?
|
Sep 3 |
Moderna’s updated COVID-19 vaccine wins U.K. approval (update)
|
Sep 3 |
Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1
|
Sep 2 |
Novavax Stock Up 9% on FDA Nod for Updated COVID-19 Vaccine
|
Sep 2 |
Novavax wins FDA emergency approval for updated Covid-19 vaccine
|
Sep 2 |
Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
|
Sep 1 |
Street Calls of the Week: Moderna upgraded, downgrade for Hershey
|
Aug 31 |
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
|